We are live on
!
Find out more
SP
Saranac Partners Portfolio holdings
AUM
$343M
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.4%
1 Year Est. Return
+11.5%
3 Year Est. Return
+68.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$256M
AUM Growth
-$296M
(-54%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-87.66%
Top 10 Holdings %
Top 10 Hldgs %
40.19%
Holding
237
New
7
Increased
43
Reduced
13
Closed
160
Avg Time Held Equity + Options
4.1
quarters
Top 10 Avg Time Held Equity + Options
2.2
quarters
Top 20 Avg Time Held Equity + Options
2.9
quarters
Avg Time Held Equity only
4.3
quarters
Top 10 Avg Time Held Equity only
2.2
quarters
Top 20 Avg Time Held Equity only
2.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$7.5M |
| 2 |
Canadian Pacific Kansas City
CP
|
+$5.92M |
| 3 |
Amazon
AMZN
|
+$3.65M |
| 4 |
Microsoft
MSFT
|
+$2.91M |
| 5 |
Ametek
AME
|
+$2.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$8.08M |
| 2 |
Quanta Services
PWR
|
+$3.83M |
| 3 |
Broadcom
AVGO
|
+$1.59M |
| 4 |
AstraZeneca
AZN
|
+$876K |
| 5 |
L3Harris
LHX
|
+$600K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.75% |
| 2 | Healthcare | 14.92% |
| 3 | Financials | 14.06% |
| 4 | Consumer Discretionary | 10.31% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
iShares MSCI United Kingdom ETF
EWU
$3.65B
| – | – |
-3,459
| Closed | -$145K | – |
|
|
FITB
102
Fifth Third Bancorp
FITB
$46B
| – | – |
-2,390
| Closed | -$106K | – |
|
103
Gilead Sciences
GILD
$182B
| – | – |
-1,060
| Closed | -$118K | – |
|
104
iShares Bitcoin Trust
IBIT
$65.4B
| – | – |
-1,550
| Closed | -$101K | – |
|
105
Intel
INTC
$566B
| – | – |
-2,385
| Closed | -$80.5K | – |
|
106
International Paper
IP
$16.9B
| – | – |
-2,411
| Closed | -$112K | – |
|
107
JD.com
JD
$36.3B
| – | – |
-3,427
| Closed | -$120K | – |
|
108
Jackson Financial
JXN
$9.01B
| – | – |
-66
| Closed | -$6.68K | – |
|
109
Kimberly-Clark
KMB
$32.5B
| – | – |
-1,205
| Closed | -$150K | – |
|
110
Linde
LIN
$222B
| – | – |
-62
| Closed | -$29.5K | – |
|
111
Lumentum
LITE
$95B
| – | – |
-800
| Closed | -$130K | – |
|
112
LyondellBasell Industries
LYB
$19.5B
| – | – |
-1,725
| Closed | -$84.6K | – |
|
113
Manchester United
MANU
$3.51B
| – | – |
-11,140
| Closed | -$169K | – |
|
114
McDonald's
MCD
$168B
| – | – |
-122
| Closed | -$37K | – |
|
115
iShares MSCI China ETF
MCHI
$5.88B
| – | – |
-1,050
| Closed | -$69.1K | – |
|
116
Mondelez International
MDLZ
$77.4B
| – | – |
-1,765
| Closed | -$110K | – |
|
117
Medtronic
MDT
$112B
| – | – |
-173
| Closed | -$16.3K | – |
|
118
NextEra Energy
NEE
$161B
| – | – |
-1,520
| Closed | -$115K | – |
|
119
Northrop Grumman
NOC
$68.8B
| – | – |
-90
| Closed | -$54.8K | – |
|
120
NetApp
NTAP
$45.4B
| – | – |
-955
| Closed | -$113K | – |
|
121
Northern Trust
NTRS
$30.8B
| – | – |
-1,000
| Closed | -$135K | – |
|
122
Nu Holdings
NU
$74.3B
| – | – |
-7,330
| Closed | -$117K | – |
|
123
Oneok
OKE
$56.9B
| – | – |
-1,285
| Closed | -$93.8K | – |
|
124
Procter & Gamble
PG
$350B
| – | – |
-196
| Closed | -$30.1K | – |
|
125
PJT Partners
PJT
$3.47B
| – | – |
-7
| Closed | -$1.24K | – |
|
Similar funds
OIC
NRW
WA
SAAM
ITB
CP
BL
JCM
Saranac Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Saranac Partners held 237 positions worth $256M, down 54% from $552M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Saranac Partners withdrew a net $224M in Q4 2025, closing 160 positions and reducing 13 holdings. Its most notable exit was AstraZeneca, an estimated $876K position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Saranac Partners opened a new position in Bank of America worth $7.81M.
- Saranac Partners's largest Q4 2025 buy was Bank of America: 141,810 shares worth $7.81M.
- Saranac Partners added most to Amazon in Q4 2025, an estimated $3.65M increase.
- Saranac Partners's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $8.08M.
- Saranac Partners fully exited AstraZeneca in Q4 2025, selling an estimated $876K.
- Saranac Partners's ten largest holdings make up 40% of its $256M portfolio in Q4 2025.
- Saranac Partners opened 7 new positions and closed 160 in Q4 2025.
- Saranac Partners's portfolio value fell 54% quarter-over-quarter to $256M.
Based on Saranac Partners's 13F filing for Q4 2025, filed 6 Feb 2026.